OraSure Technologies Total Current Assets 2010-2024 | OSUR

OraSure Technologies total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
OraSure Technologies Annual Total Current Assets
(Millions of US $)
2023 $386
2022 $325
2021 $299
2020 $289
2019 $225
2018 $219
2017 $222
2016 $156
2015 $137
2014 $131
2013 $120
2012 $120
2011 $53
2010 $97
2009 $105
OraSure Technologies Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $351
2024-03-31 $349
2023-12-31 $386
2023-09-30 $356
2023-06-30 $342
2023-03-31 $344
2022-12-31 $325
2022-09-30 $280
2022-06-30 $267
2022-03-31 $268
2021-12-31 $299
2021-09-30 $289
2021-06-30 $285
2021-03-31 $292
2020-12-31 $289
2020-09-30 $303
2020-06-30 $318
2020-03-31 $223
2019-12-31 $225
2019-09-30 $223
2019-06-30 $209
2019-03-31 $205
2018-12-31 $219
2018-09-30 $208
2018-06-30 $202
2018-03-31 $197
2017-12-31 $222
2017-09-30 $209
2017-06-30 $206
2017-03-31 $181
2016-12-31 $156
2016-09-30 $151
2016-06-30 $146
2016-03-31 $134
2015-12-31 $137
2015-09-30 $142
2015-06-30 $125
2015-03-31 $123
2014-12-31 $131
2014-09-30 $130
2014-06-30 $116
2014-03-31 $112
2013-12-31 $120
2013-09-30 $111
2013-06-30 $108
2013-03-31 $113
2012-12-31 $120
2012-09-30 $124
2012-06-30 $52
2012-03-31 $50
2011-12-31 $53
2011-09-30 $47
2011-06-30 $97
2011-03-31 $94
2010-12-31 $97
2010-09-30 $97
2010-06-30 $99
2010-03-31 $98
2009-12-31 $105
2009-09-30 $106
2009-06-30 $100
2009-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.321B $0.405B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $199.879B 25.82
Stryker (SYK) United States $137.705B 32.18
Boston Scientific (BSX) United States $121.595B 37.03
Medtronic (MDT) Ireland $113.026B 16.82
EssilorLuxottica (ESLOY) France $104.378B 0.00
Haleon (HLN) United Kingdom $48.118B 35.17
Lonza Group Ag (LZAGY) Switzerland $45.437B 0.00
ResMed (RMD) United States $34.974B 30.79
Koninklijke Philips (PHG) Netherlands $29.016B 22.05
Terumo (TRUMY) Japan $27.876B 39.37
Zimmer Biomet Holdings (ZBH) United States $21.644B 13.63
Baxter (BAX) United States $20.086B 13.62
Insulet (PODD) United States $16.555B 69.65
Smith & Nephew SNATS (SNN) United Kingdom $13.426B 0.00
Bio-Rad Laboratories (BIO) United States $9.489B 31.44
Demant (WILYY) Denmark $9.197B 0.00
BellRing Brands (BRBR) United States $7.672B 32.44
Lantheus Holdings (LNTH) United States $7.508B 18.02
ICU Medical (ICUI) United States $4.304B 41.08
TG Therapeutics (TGTX) United States $3.909B 41.39
Haemonetics (HAE) United States $3.870B 19.14
Perrigo (PRGO) Ireland $3.841B 12.14
GN Store Nord (GNNDY) Denmark $3.758B 22.64
Neogen (NEOG) United States $3.736B 39.18
Prestige Consumer Healthcare (PBH) United States $3.644B 18.16
Envista Holdings (NVST) United States $3.298B 17.60
QuidelOrtho (QDEL) United States $3.108B 19.59
Agios Pharmaceuticals (AGIO) United States $2.591B 0.00
Maravai LifeSciences Holdings (MRVI) United States $2.311B 0.00
Green Thumb Industries (GTBIF) United States $2.171B 36.43
LeMaitre Vascular (LMAT) United States $1.996B 53.20
AdaptHealth (AHCO) United States $1.524B 11.00
InMode (INMD) Israel $1.466B 9.34
Warby Parker (WRBY) United States $1.466B 0.00
AtriCure (ATRC) United States $1.363B 0.00
Owens & Minor (OMI) United States $1.219B 9.41
Verano Holdings (VRNOF) United States $1.114B 0.00
BioLife Solutions (BLFS) United States $1.094B 0.00
Evolus (EOLS) United States $1.023B 0.00
PetIQ (PETQ) United States $0.920B 23.32
Phibro Animal Health (PAHC) United States $0.897B 18.61
National Vision Holdings (EYE) United States $0.864B 27.48
Cresco Labs (CRLBF) United States $0.801B 0.00
Surmodics (SRDX) United States $0.561B 119.09
Quanterix (QTRX) United States $0.543B 0.00
ZimVie (ZIMV) United States $0.454B 42.23
VAREX IMAGING (VREX) United States $0.451B 13.62
Valneva SE (VALN) France $0.422B 0.00
Canopy Growth (CGC) Canada $0.406B 0.00
Jin Medical (ZJYL) China $0.397B 0.00
TerrAscend (TSNDF) Canada $0.333B 0.00
Cerus (CERS) United States $0.330B 0.00
Aurora Cannabis (ACB) Canada $0.320B 0.00
Biote (BTMD) United States $0.319B 14.70
Viemed Healthcare (VMD) United States $0.287B 30.79
Sanara MedTech (SMTI) United States $0.272B 0.00
Zynex (ZYXI) United States $0.260B 45.44
Utah Medical Products (UTMD) United States $0.234B 15.52
Ayr Wellness (AYRWF) United States $0.232B 0.00
Omeros (OMER) United States $0.228B 0.00
MacroGenics (MGNX) United States $0.207B 0.00
Organigram Holdings (OGI) Canada $0.196B 0.00
High Tide (HITI) Canada $0.170B 70.33
Capricor Therapeutics (CAPR) United States $0.167B 0.00
FitLife Brands (FTLF) United States $0.153B 20.62
Brainsway (BWAY) Israel $0.140B 168.00
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Rockwell Medical (RMTI) United States $0.125B 0.00
Quipt Home Medical (QIPT) United States $0.124B 0.00
Veru (VERU) United States $0.113B 0.00
Fonar (FONR) United States $0.110B 11.15
Jushi Holdings (JUSHF) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.099B 24.20
InterCure (INCR) Israel $0.085B 14.31
Safety Shot (SHOT) United States $0.082B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
Zevia PBC (ZVIA) United States $0.076B 0.00
Cellectar Biosciences (CLRB) United States $0.075B 0.00
Modular Medical (MODD) United States $0.073B 0.00
MariMed (MRMD) United States $0.065B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.056B 3.63
Exagen (XGN) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.041B 0.00
Apyx Medical (APYX) United States $0.036B 0.00
Bright Green (BGXX) United States $0.028B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Meihua Medical Technologies (MHUA) China $0.026B 0.00
Nephros (NEPH) United States $0.019B 0.00
GlucoTrack (GCTK) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Agape ATP (ATPC) $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
Akanda (AKAN) United Kingdom $0.000B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
United-Guardian (UG) United States $0.000B 20.47
SNDL (SNDL) Canada $0.000B 0.00